Flarin Revenue and Competitors
Estimated Revenue & Valuation
- Flarin's estimated annual revenue is currently $502.5k per year.
- Flarin's estimated revenue per employee is $100,500
Employee Data
- Flarin has 5 Employees.
- Flarin grew their employee count by 150% last year.
Flarin's People
Name | Title | Email/Phone |
---|
Flarin Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.5M | 25 | -32% | N/A | N/A |
#2 | $0.5M | 5 | 150% | N/A | N/A |
What Is Flarin?
Flarin is the first and only over-the-counter (OTC) lipid formulated ibuprofen 200mg which helps relieve flaring joint pain and inflammation. It is indicated for the relief from rheumatic or muscular pain, back pain, and also for the relief of pain of non-serious arthritic conditions, caused by swelling, stiffness and inflammation. It has been clinically proven to be as effective as prescription strength ibuprofen (2400 mg) at reducing joint pain.A recent clinical study conducted at 27 primary care centres in 462 patients, the first of its kind to focus on flaring joints provided good clinical evidence to show that combining ibuprofen in a lipid formulation can deliver effective flare-up control. Flarin comes in packs of 30 and 12 soft capsules and derives from infirst Ltd portfolio of patented technologies. Essential information: Flarin 200mg soft capsules. Contains ibuprofen. Relief from rheumatic or muscular pain, also for the relief of pain of non-serious arthritic conditions (caused by swelling, stiffness and inflammation of joints), joint pain, back pain. Always read the leaflet. https://flarin.co.uk/wp-content/uploads/2021/10/PFLA_PIL_014_proof_no-panel.pdfhttps://flarin.co.uk/wp-content/uploads/2021/10/GFLA_PIL_005-Proof_No-panel.pdf
keywords:N/AN/A
Total Funding
5
Number of Employees
$502.5k
Revenue (est)
150%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 5 | 0% | $7M |
#2 | $0.4M | 5 | -37% | N/A |
#3 | $0.6M | 5 | -37% | N/A |
#4 | $0.4M | 5 | -58% | N/A |
#5 | $0.3M | 5 | -17% | N/A |